|
|||||
       |
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds 
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal 
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection  One comment - (Comments are closed)  New products  Africa, biomedical, chemistry, clinical trials, engineering, entrepreneurs, health care, licensing, medical device, pharmaceuticals, physical sciences, university 
Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, chemistry, engineering, equity, genomics, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences 
A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M One comment - (Comments are closed) Finance, Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease. . . . → Read More: Start-Up Licensing Antibody Eye Drops for Dry Eye Disease Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, university 
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K., university 
A university lab created and licensed to a biotechnology company a model human ovary made of functioning cells for female reproductive health applications. . . . → Read More: Human Ovary Organoid Model Demonstrated, Licensed Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, medical device, stem cells, university 
A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round. . . . → Read More: Allergy Antibody Biotech Gains $40M in New Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data. . . . → Read More: Start-Up Creating Software to Simplify Biomedical Analytics Comments are closed Intellectual property, New products biomedical, computer science, engineering, entrepreneurs, genomics, licensing, life sciences, mathematics, physical sciences, software, university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts